247.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUM Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$249.87
Aprire:
$249.51
Volume 24 ore:
1.76M
Relative Volume:
0.95
Capitalizzazione di mercato:
$29.84B
Reddito:
$117.76B
Utile/perdita netta:
$1.21B
Rapporto P/E:
24.85
EPS:
9.95
Flusso di cassa netto:
$2.39B
1 W Prestazione:
+3.90%
1M Prestazione:
-2.11%
6M Prestazione:
-15.68%
1 anno Prestazione:
-31.12%
Humana Inc Stock (HUM) Company Profile
Nome
Humana Inc
Settore
Industria
Telefono
(502) 580-1000
Indirizzo
500 W MAIN ST, LOUISVILLE, KY
Confronta HUM con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
HUM
Humana Inc
|
247.26 | 30.05B | 117.76B | 1.21B | 2.39B | 9.95 |
![]()
UNH
Unitedhealth Group Inc
|
237.77 | 226.39B | 422.82B | 21.30B | 25.27B | 23.08 |
![]()
CVS
Cvs Health Corp
|
62.47 | 78.76B | 386.64B | 4.53B | 4.78B | 3.58 |
![]()
CI
Cigna Group
|
262.23 | 71.36B | 261.22B | 5.02B | 3.94B | 18.32 |
![]()
ELV
Elevance Health Inc
|
274.66 | 63.74B | 189.25B | 5.36B | 5.34B | 23.50 |
Humana Inc Stock (HUM) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-01 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2024-11-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2024-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
2024-10-07 | Downgrade | Jefferies | Buy → Hold |
2024-10-07 | Downgrade | TD Cowen | Buy → Hold |
2024-10-03 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-10-02 | Downgrade | BofA Securities | Neutral → Underperform |
2024-10-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
2024-10-02 | Downgrade | Stephens | Overweight → Equal-Weight |
2024-06-26 | Iniziato | Piper Sandler | Overweight |
2024-06-24 | Iniziato | Morgan Stanley | Equal-Weight |
2024-04-02 | Downgrade | BofA Securities | Buy → Neutral |
2024-03-22 | Iniziato | Raymond James | Mkt Perform |
2024-03-13 | Downgrade | Argus | Buy → Hold |
2024-03-06 | Iniziato | Barclays | Equal Weight |
2024-01-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2024-01-25 | Downgrade | Deutsche Bank | Buy → Hold |
2023-12-12 | Aggiornamento | Argus | Hold → Buy |
2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
2023-07-07 | Downgrade | JP Morgan | Overweight → Neutral |
2023-06-23 | Downgrade | Argus | Buy → Hold |
2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
2022-10-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
2022-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2022-06-17 | Iniziato | Loop Capital | Buy |
2022-05-27 | Iniziato | Bernstein | Mkt Perform |
2022-04-13 | Aggiornamento | UBS | Neutral → Buy |
2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-12-14 | Iniziato | Goldman | Neutral |
2021-11-04 | Reiterato | Barclays | Overweight |
2021-11-04 | Reiterato | Credit Suisse | Outperform |
2021-11-04 | Reiterato | Morgan Stanley | Overweight |
2021-11-04 | Reiterato | Oppenheimer | Outperform |
2021-11-04 | Reiterato | RBC Capital Mkts | Outperform |
2021-09-27 | Iniziato | SVB Leerink | Outperform |
2021-09-10 | Iniziato | Cowen | Outperform |
2021-09-09 | Ripresa | Barclays | Overweight |
2021-07-09 | Iniziato | Seaport Global Securities | Neutral |
2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
2021-01-04 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2020-10-02 | Iniziato | Bernstein | Mkt Perform |
2020-07-01 | Iniziato | SVB Leerink | Outperform |
2020-06-16 | Downgrade | Cowen | Outperform → Market Perform |
2020-06-05 | Iniziato | Goldman | Buy |
2020-01-03 | Reiterato | JP Morgan | Overweight |
2019-10-18 | Iniziato | Mizuho | Buy |
2019-09-30 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
2019-09-12 | Iniziato | Deutsche Bank | Hold |
2019-08-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2019-04-23 | Iniziato | UBS | Neutral |
2019-01-14 | Iniziato | Stephens | Overweight |
2018-12-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-11-08 | Reiterato | BofA/Merrill | Buy |
2018-09-13 | Iniziato | Barclays | Overweight |
2018-07-12 | Ripresa | Morgan Stanley | Overweight |
2018-07-06 | Reiterato | Piper Jaffray | Overweight |
2018-06-01 | Ripresa | Citigroup | Buy |
2018-02-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2018-02-08 | Reiterato | Leerink Partners | Outperform |
2018-01-12 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Humana Inc Borsa (HUM) Ultime notizie
Natixis Advisors LLC Has $28.91 Million Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
What are the latest earnings results for Humana Inc.Free Trading Psychology Coaching - jammulinksnews.com
Wall Street Zen Downgrades Humana (NYSE:HUM) to Hold - MarketBeat
National Senior Games 2025Humana Game Changers - Goshen News
Federated Hermes Inc. Has $22.04 Million Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
FY2025 EPS Estimates for Humana Boosted by Leerink Partnrs - MarketBeat
Humana Inc. (NYSE:HUM) Shares Purchased by Meeder Asset Management Inc. - MarketBeat
Morgan Stanley Lowers Humana (NYSE:HUM) Price Target to $277.00 - MarketBeat
Piper Sandler Cuts Humana (NYSE:HUM) Price Target to $272.00 - MarketBeat
Why Humana (HUM) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Howard Capital Management Inc. Reduces Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Insurer Humana raises annual profit forecast as medical costs stabilize - MSN
TD Asset Management Inc Sells 2,387 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Private Advisor Group LLC Makes New $443,000 Investment in Humana Inc. (NYSE:HUM) - MarketBeat
Exact Sciences expands partnership with Humana to improve colorectal cancer screening - Yahoo Finance
High Ground Investment Management LLP Buys 6,095 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Q2 2025 Earnings Call Transcript - MSN
HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength? - MSN
Skandinaviska Enskilda Banken AB publ Grows Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Texas Yale Capital Corp. Takes Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana (NYSE:HUM) Shares Gap UpWhat's Next? - MarketBeat
Humana (HUM) Target Price Lowered by Morgan Stanley | HUM Stock News - GuruFocus
Humana (HUM) Target Price Reduced by Piper Sandler - GuruFocus
Piper Sandler Lowers Price Target for Humana (HUM) to $272 | HUM Stock News - GuruFocus
Humana price target lowered to $272 from $288 at Piper Sandler - TipRanks
8,732 Shares in Humana Inc. (NYSE:HUM) Purchased by Bellwether Advisors LLC - MarketBeat
Humana Inc. (NYSE:HUM) Shares Acquired by Bayforest Capital Ltd - MarketBeat
Humana reports lower Q2 earnings - Insurance Business America
Banque Cantonale Vaudoise Takes Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Revises Profit Outlook as Medicare Costs Find Stability - IndiaMedToday
Exact Sciences, Humana partner to offer Cologuard Plus in-network By Investing.com - Investing.com Nigeria
Exact Sciences, Humana partner to offer Cologuard Plus in-network - Investing.com Australia
Humana (NYSE:HUM) Releases FY 2025 Earnings Guidance - MarketBeat
Exact Sciences expands Humana partnership for colorectal cancer screening - StreetInsider
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test - Business Wire
Humana (HUM) Jumps 12.4% on Higher Revenues, Growth Outlook - MSN
Humana Inc. (NYSE:HUM) Shares Sold by Pacer Advisors Inc. - MarketBeat
Humana Inc (HUM) Q2 2025 Earnings Call Highlights: Strong EPS Ou - GuruFocus
Humana Inc (HUM) Q2 2025 Earnings Call Highlights: Strong EPS Outlook and Strategic Growth Initiatives - GuruFocus
Humana Inc. Reports Strong Q2 2025 Earnings and Raises Guidance - TipRanks
Humana’s Earnings Call: Positive Outlook Amid Challenges - TipRanks
Humana's early retirement offering to some employees raises concern for local economist - WDRB
Neal-Clinton: 2025 Annual Enrollment Update On Humana, UnitedHealthcare & Aetna - Los Alamos Daily Post
Humana outperforms on MA, raises guidance - Healthcare Finance News
Humana, SoFi, LendingClub, Generac, Palo Alto, Teradyne, Harley-Davidson, Peloton, and More Movers - Barron's
EXCLUSIVE: Humana to offer employees a buyout in form of early retirement option - The Courier-Journal
HUMANA INC SEC 10-Q Report - TradingView
Humana’s Strategy Surge: A Closer Look - StocksToTrade
Humana's Q2 2025 Earnings Call: Unpacking Key Contradictions in Stars Performance, Medicaid Strategy, and Investment Spending - AInvest
Humana Inc Azioni (HUM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):